#PHARMA: Therapix Biosciences are developing 'medicinal cannabis' for Tourette's and sleep apnea
Josh Blacher, CFO at Therapix Biosciences, describes how his company are developing a therapeutic approach to obstructive sleep apnea, and in parallel are developing a synthetic cannabinoid-based...